| DNA methylation in glioblastoma: impact on gene expression and clinical outcome A Etcheverry, M Aubry, M De Tayrac, E Vauleon, R Boniface, F Guenot, ... BMC genomics 11, 1-11, 2010 | 271 | 2010 |
| Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach M De Tayrac, S Lê, M Aubry, J Mosser, F Husson BMC genomics 10, 1-17, 2009 | 144 | 2009 |
| Integrative genome‐wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression M Tayrac, A Etcheverry, M Aubry, S Saïkali, A Hamlat, V Quillien, AL Treut, ... Genes, Chromosomes and Cancer 48 (1), 55-68, 2009 | 105 | 2009 |
| ‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity M Aubry, M de Tayrac, A Etcheverry, A Clavreul, S Saikali, P Menei, ... Oncotarget 6 (14), 12094, 2015 | 101 | 2015 |
| Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions T Avril, S Saikali, E Vauleon, A Jary, A Hamlat, M De Tayrac, J Mosser, ... Journal of neuroimmunology 225 (1-2), 22-33, 2010 | 88 | 2010 |
| A 4-gene signature associated with clinical outcome in high-grade gliomas M de Tayrac, M Aubry, S Saïkali, A Etcheverry, C Surbled, F Guénot, ... Clinical Cancer Research 17 (2), 317-327, 2011 | 84 | 2011 |
| Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis JM Lemée, A Clavreul, M Aubry, E Com, M de Tayrac, PA Eliat, C Henry, ... Journal of neuro-oncology 122, 53-61, 2015 | 76 | 2015 |
| Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia V Gandemer, AG Rio, M De Tayrac, V Sibut, S Mottier, B Ly Sunnaram, ... BMC genomics 8, 1-15, 2007 | 76 | 2007 |
| Identification of potential mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP) adult exposure in the liver using a systems biology approach A Eveillard, F Lasserre, M de Tayrac, A Polizzi, S Claus, C Canlet, ... Toxicology and applied pharmacology 236 (3), 282-292, 2009 | 75 | 2009 |
| Mutational spectrum in holoprosencephaly shows that FGF is a new major signaling pathway C Dubourg, W Carré, H Hamdi‐Rozé, C Mouden, J Roume, B Abdelmajid, ... Human mutation 37 (12), 1329-1339, 2016 | 65 | 2016 |
| Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis M De Tayrac, MP Roth, AM Jouanolle, H Coppin, G Le Gac, A Piperno, ... Journal of Hepatology 62 (3), 664-672, 2015 | 61 | 2015 |
| Recent advances in understanding inheritance of holoprosencephaly C Dubourg, A Kim, E Watrin, M de Tayrac, S Odent, V David, V Dupé American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2018 | 56 | 2018 |
| Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas M de Tayrac, S Saikali, M Aubry, P Bellaud, R Boniface, V Quillien, ... PloS one 8 (9), e73332, 2013 | 53 | 2013 |
| MITF reprograms the extracellular matrix and focal adhesion in melanoma R Dilshat, V Fock, C Kenny, I Gerritsen, RMJ Lasseur, J Travnickova, ... Elife 10, e63093, 2021 | 50 | 2021 |
| Integrated clinical and omics approach to rare diseases: novel genes and oligogenic inheritance in holoprosencephaly A Kim, C Savary, C Dubourg, W Carré, C Mouden, H Hamdi-Roze, ... Brain 142 (1), 35-49, 2019 | 47 | 2019 |
| Rare and low frequency variant stratification in the UK population: description and impact on association tests MC Babron, M De Tayrac, DN Rutledge, E Zeggini, E Génin Public Library of Science 7 (10), e46519, 2012 | 44 | 2012 |
| CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart V Gandemer, M Aubry, M Roussel, AG Rio, M de Tayrac, A Vallee, ... Leukemia research 34 (4), 430-437, 2010 | 42 | 2010 |
| A framework for validating AI in precision medicine: considerations from the European ITFoC consortium R Tsopra, X Fernandez, C Luchinat, L Alberghina, H Lehrach, M Vanoni, ... BMC medical informatics and decision making 21, 1-14, 2021 | 38 | 2021 |
| Homozygous STIL Mutation Causes Holoprosencephaly and Microcephaly in Two Siblings C Mouden, M de Tayrac, C Dubourg, S Rose, W Carre, H Hamdi-Roze, ... PLoS One 10 (2), e0117418, 2015 | 37 | 2015 |
| GNPAT variant associated with severe iron overload in HFE hemochromatosis E Bardou‐Jacquet, M De Tayrac, J Mosser, Y Deugnier Hepatology 62 (6), 1917-1918, 2015 | 32 | 2015 |
